Download FREE Report Sample
Download Free sampleA?hospital-acquired infection?(HAI) is an?infection?whose development is favoured by a?hospital?environment, such as one?acquired?by a patient during a?hospital?visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infection (UTI), and surgical site infection (SSI).
Hospital-Acquired Infection Diagnostic Market contains market size and forecasts of Hospital-Acquired Infection (HAI) Diagnostic in Global, including the following market information:
Global Hospital-Acquired Infection (HAI) Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hospital-Acquired Infection (HAI) Diagnostic market was valued at 4991.3 million in 2021 and is projected to reach US$ 7439.1 million by 2028, at a CAGR of 5.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Molecular Diagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hospital-Acquired Infection (HAI) Diagnostic include bioM?rieux, Abbott Laboratories, Alere, Inc., Roche, Siemens Healthcare, Becton Dickenson, Cepheid Inc., Thermo Fisher Scientific and Seegene, Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hospital-Acquired Infection (HAI) Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital-Acquired Infection (HAI) Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hospital-Acquired Infection (HAI) Diagnostic Market Segment Percentages, by Type, 2021 (%)
Molecular Diagnostics
Blood Tests
Urinalysis
Global Hospital-Acquired Infection (HAI) Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hospital-Acquired Infection (HAI) Diagnostic Market Segment Percentages, by Application, 2021 (%)
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
Global Hospital-Acquired Infection (HAI) Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hospital-Acquired Infection (HAI) Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital-Acquired Infection (HAI) Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hospital-Acquired Infection (HAI) Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
bioM?rieux
Abbott Laboratories
Alere, Inc.
Roche
Siemens Healthcare
Becton Dickenson
Cepheid Inc.
Thermo Fisher Scientific
Seegene, Inc.
Qiagen
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
